Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
BRAF kinase inhibitors are generally used as targeted therapy drugs for the treatment of carcinomas such as RCC, NSCLC, and melanomas caused by mutations of the BRAF gene.
These drugs directly target BRAF protein and inhibit the growth of tumors in patients with metastatic melanoma. Such results delivered by the BRAF kinase inhibitors has encouraged several R&D teams to extend research on other applications. Moreover, many BRAF kinase inhibitor drugs are in the final stages of development and are expected to be launched during the forecast period.
The report details the trend, potential and market size of BRAF Kinase Inhibitors market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of BRAF Kinase Inhibitorsmarket, defines the market attractiveness level of BRAF Kinase Inhibitors market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of BRAF Kinase Inhibitors industry, describes the types of BRAF Kinase Inhibitors market, the applications of major players and the market size, and deeply analyzes the current situation of the global BRAF Kinase Inhibitors market and the development prospects and opportunities of BRAF Kinase Inhibitors industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global BRAF Kinase Inhibitors market in Chapter 13.
By Player:
Array BioPharma Inc
Bayer AG
F Hoffmann-La Roche Ltd
Novartis AG
By Type:
Dabrafenib
Sorafenib
Vemurafenib
Encorafenib
By End-User:
Hospital
Medical Research Institute
Clinic
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 BRAF Kinase Inhibitors Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 BRAF Kinase Inhibitors Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 BRAF Kinase Inhibitors Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 BRAF Kinase Inhibitors Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise BRAF Kinase Inhibitors Market Analysis and Outlook to 2022
-
7.1 Global BRAF Kinase Inhibitors Consumption (2017-2022)
-
7.2 United States BRAF Kinase Inhibitors Consumption (2017-2022)
-
7.3 Europe BRAF Kinase Inhibitors Consumption (2017-2022)
-
7.4 China BRAF Kinase Inhibitors Consumption (2017-2022)
-
7.5 Japan BRAF Kinase Inhibitors Consumption (2017-2022)
-
7.6 India BRAF Kinase Inhibitors Consumption (2017-2022)
-
7.7 South Korea BRAF Kinase Inhibitors Consumption (2017-2022)
8 Region and Country-wise BRAF Kinase Inhibitors Market Analysis and Outlook to 2028
-
8.1 Global BRAF Kinase Inhibitors Consumption Forecast (2022-2028)
-
8.2 United States BRAF Kinase Inhibitors Consumption Forecast (2022-2028)
-
8.3 Europe BRAF Kinase Inhibitors Consumption Forecast (2022-2028)
-
8.4 China BRAF Kinase Inhibitors Consumption Forecast (2022-2028)
-
8.5 Japan BRAF Kinase Inhibitors Consumption Forecast (2022-2028)
-
8.6 India BRAF Kinase Inhibitors Consumption Forecast (2022-2028)
-
8.7 South Korea BRAF Kinase Inhibitors Consumption Forecast (2022-2028)
9 Global BRAF Kinase Inhibitors Market Outlook by Types and Applications to 2022
-
9.1 Global BRAF Kinase Inhibitors Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Dabrafenib Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Sorafenib Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Vemurafenib Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Encorafenib Consumption and Growth Rate (2017-2022)
-
9.2 Global BRAF Kinase Inhibitors Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Medical Research Institute Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Other Consumption and Growth Rate (2017-2022)
10 Global BRAF Kinase Inhibitors Market Outlook by Types and Applications to 2028
-
10.1 Global BRAF Kinase Inhibitors Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Dabrafenib Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Sorafenib Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Vemurafenib Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Encorafenib Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global BRAF Kinase Inhibitors Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Medical Research Institute Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global BRAF Kinase Inhibitors Import and Export Analysis (Top 5 Countries)
-
11.1 Global BRAF Kinase Inhibitors Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global BRAF Kinase Inhibitors Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 BRAF Kinase Inhibitors Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global BRAF Kinase Inhibitors Market Competitive Analysis
-
14.1 Array BioPharma Inc
-
14.1.1 Array BioPharma Inc Company Details
-
14.1.2 Array BioPharma Inc BRAF Kinase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Array BioPharma Inc BRAF Kinase Inhibitors Product and Service
-
14.2 Bayer AG
-
14.2.1 Bayer AG Company Details
-
14.2.2 Bayer AG BRAF Kinase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Bayer AG BRAF Kinase Inhibitors Product and Service
-
14.3 F Hoffmann-La Roche Ltd
-
14.3.1 F Hoffmann-La Roche Ltd Company Details
-
14.3.2 F Hoffmann-La Roche Ltd BRAF Kinase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 F Hoffmann-La Roche Ltd BRAF Kinase Inhibitors Product and Service
-
14.4 Novartis AG
-
14.4.1 Novartis AG Company Details
-
14.4.2 Novartis AG BRAF Kinase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Novartis AG BRAF Kinase Inhibitors Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of BRAF Kinase Inhibitors
-
Figure BRAF Kinase Inhibitors Picture
-
Table Global BRAF Kinase Inhibitors Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global BRAF Kinase Inhibitors Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global BRAF Kinase Inhibitors Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global BRAF Kinase Inhibitors Consumption by Country (2017-2022)
-
Figure United States BRAF Kinase Inhibitors Consumption and Growth Rate (2017-2022)
-
Table Europe BRAF Kinase Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure China BRAF Kinase Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Japan BRAF Kinase Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure India BRAF Kinase Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure South Korea BRAF Kinase Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global BRAF Kinase Inhibitors Consumption Forecast by Country (2022-2028)
-
Figure United States BRAF Kinase Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe BRAF Kinase Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure China BRAF Kinase Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan BRAF Kinase Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure India BRAF Kinase Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea BRAF Kinase Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Dabrafenib Consumption and Growth Rate (2017-2022)
-
Figure Global Sorafenib Consumption and Growth Rate (2017-2022)
-
Figure Global Vemurafenib Consumption and Growth Rate (2017-2022)
-
Figure Global Encorafenib Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Medical Research Institute Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Dabrafenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Sorafenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Vemurafenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Encorafenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Medical Research Institute Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global BRAF Kinase Inhibitors Import by Region (Top 5 Countries) (2017-2028)
-
Table Global BRAF Kinase Inhibitors Export by Region (Top 5 Countries) (2017-2028)
-
Table Array BioPharma Inc (Foundation Year, Company Profile and etc.)
-
Table Array BioPharma Inc BRAF Kinase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Array BioPharma Inc BRAF Kinase Inhibitors Product and Service
-
Table Bayer AG (Foundation Year, Company Profile and etc.)
-
Table Bayer AG BRAF Kinase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer AG BRAF Kinase Inhibitors Product and Service
-
Table F Hoffmann-La Roche Ltd (Foundation Year, Company Profile and etc.)
-
Table F Hoffmann-La Roche Ltd BRAF Kinase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffmann-La Roche Ltd BRAF Kinase Inhibitors Product and Service
-
Table Novartis AG (Foundation Year, Company Profile and etc.)
-
Table Novartis AG BRAF Kinase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG BRAF Kinase Inhibitors Product and Service
-
